ZEVRA THERAPEUTICS, INC. Quarterly Nonoperating Income (Expense) in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Zevra Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2014 to Q2 2024.
  • Zevra Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $3.94M, a 9.29% increase year-over-year.
  • Zevra Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $8.17M, a 56.7% decline year-over-year.
  • Zevra Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $3.56M, a 77.4% decline from 2022.
  • Zevra Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $15.8M.
  • Zevra Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$16.3M, a 126% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $8.17M $3.94M +$335K +9.29% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $7.84M $3.79M +$4.28M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $3.56M -$1.06M -$16.8M -107% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $20.4M $1.5M +$1.52M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $18.9M $3.61M +$3.6M +35950% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $15.3M -$489K -$480K -5333% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $15.8M $15.8M +$15.6M +9023% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $151K -$23K -$486K -105% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $637K $10K -$360K -97.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $997K -$9K +$17.2M +99.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$16.3M $173K +$1.82M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-07
Q3 2021 -$18.1M $463K +$2.29M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$20.4M $370K +$2.1M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$22.5M -$17.3M -$15.3M -772% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$7.19M -$1.64M -$7K -0.43% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$7.18M -$1.83M -$1.66M -989% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$5.52M -$1.73M -$260K -17.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$5.26M -$1.98M -$1.05M -113% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$4.21M -$1.64M -$5.7M -140% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-12
Q3 2019 $1.49M -$168K -$3M -106% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-30
Q2 2019 $4.49M -$1.47M -$5.35M -138% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $9.84M -$930K +$10.5M +91.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$689K $4.07M +$6.51M Oct 1, 2018 Dec 31, 2018 10-K 2020-02-28
Q3 2018 -$7.2M $2.83M +$3.2M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$10.4M $3.88M +$2.17M +128% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$12.6M -$11.5M -$2.51M -28.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$10.1M -$2.45M -$3.34M -373% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-30
Q3 2017 -$6.72M -$373K +$2.66M +87.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$9.38M $1.7M -$17.3M -91.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 $7.96M -$8.95M -$13M -321% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 $21M $896K +$2.82M Oct 1, 2016 Dec 31, 2016 10-K 2018-03-30
Q3 2016 $18.1M -$3.03M +$212K +6.54% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-30
Q2 2016 $17.9M $19M +$42.8M Apr 1, 2016 Jun 30, 2016 10-K 2018-03-30
Q1 2016 -$24.9M $4.05M +$6.92M Jan 1, 2016 Mar 31, 2016 10-K 2018-03-30
Q4 2015 -$31.8M -$1.92M +$2.4M +55.6% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-10
Q3 2015 -$34.2M -$3.24M -$408K -14.4% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-10
Q2 2015 -$33.8M -$23.8M -$23.3M -4363% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-10
Q1 2015 -$10.6M -$2.87M -$2.53M -749% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-10
Q4 2014 -$8.03M -$4.33M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-16
Q3 2014 -$2.84M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-16
Q2 2014 -$533K Apr 1, 2014 Jun 30, 2014 10-K 2016-03-16
Q1 2014 -$338K Jan 1, 2014 Mar 31, 2014 10-K 2016-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.